Temporary circulatory support with extracorporeal membrane oxygenation (ECMO) is often the only alternative for supporting patients with refractory cardiogenic shock (RCS). In practice, this strategy is limited to a small minority of patients hospitalized in tertiary-care centres with ECMO programs. The cardiac-RESCUE program was designed to test the feasibility of providing circulatory support distant from specialized ECMO centres, for RCS patients in remote locations.
Introduction
Refractory cardiogenic shock (RCS) is defined as cardiac and circulatory failure resulting in organ hypoperfusion unresponsive to conventional medical therapies. 1 Despite recent advances, therapeutic options are limited, and RCS is almost uniformly fatal when emergency circulatory support cannot be initiated in a timely manner. 1 If such patients can be stabilized by extracorporeal membrane oxygenation (ECMO), possible outcomes include (i) ECMO weaning to recovery (bridge to recovery), (ii) heart transplantation (bridge to transplantation), or (iii) implantation of a long-term assist device (bridge to bridge). When this strategy based on temporary circulatory support is available in specialized and experienced centres, up to 40% of the patients with RCS can survive to hospital discharge in various pathophysiological situations, including acute myocarditis and acute myocardial infarction. 2 -6 Nonetheless, this strategy is currently restricted to a very limited number of tertiary-care centres with specialist capabilities for instituting and supporting ECMO. In remote hospitals, however, without ECMO capability, management of RCS patients is considerably more difficult, as transfer to tertiary centres is often essential to save the patient but is often not feasible in such medically unstable patients. We hypothesized that instituting ECMO in remote institutions followed by stabilization and transfer might be logistically feasible, allowing an improved rate of survival.
To test the feasibility of offering ECMO support to RCS patients in remote hospitals, we set up a specific program based on coordinating staff and a Mobile Unit of Cardiac Assistance (MUCA), able to initiate and manage circulatory support in institutions that do not host local circulatory support teams. This program called cardiac-RESCUE (REmote Support of the Circulation Using Extracorporeal membrane oxygenation for refractory cardiogenic shock) was initiated in January 2005.
Methods Setting
The groupe hospitalier Pitié-Salpêtrière is one of the largest extracorporeal life-support referral centres worldwide. This activity started at our own Institution and was then expanded in 2005 as an extrainstitutional service, the MUCA. The cardiac-RESCUE program included a dedicated team (coordinating staff and MUCA) and equipment (ECMO device and supplies) and was available 24 h a day and 365 days a year for any intensive care units (ICU) of Paris and its surrounding area. This programme resulted from a desire to establish a comprehensive approach to patients with advanced heart failure, integrating extrainstitutional ECMO, in-house ECMO, long-term ventricular assist devices, and heart transplantation competencies. 7, 8 The source of funding was public (Assistance Publique-Hô pitaux de Paris). This study was approved by the Ethics Committee of La Pitié-Salpêtrière Hospital for the Protection of Human Subjects. Oral informed consent for ECMO initiation was obtained from patients' relatives whenever possible. were also invited and participated in the cardiac-RESCUE program. All patients who presented with RCS to one of these facilities were considered for inclusion by the physician in charge. Refractory cardiogenic shock patient was defined as an acute or acute on chronic heart failure patient with the following two criteria: (i) the requirement of increasing inotropic doses, despite an adequate fluid management to maintain a systolic blood pressure of more than 90 mmHg and (ii) physiological evidence of visceral hypoperfusion. In some extreme situations, patients presented with witnessed cardiac arrest, and maintenance of circulation required ongoing cardiopulmonary resuscitation (CPR). All physicians in charge of patients with RCS in the remote institutions were invited to systematically contact the coordinating staff, when the patient presented with inclusion criteria, to discuss the opportunity to install or not the circulatory support. The coordinating staff (a senior cardiac surgeon and an intensivist) decided to send the MUCA (a cardiac surgeon, a perfusionist, and a nurse) in accordance with prospectively established inclusion and exclusion criteria (see Supplementary File S1). Exclusion criteria included aortic dissection, severe aortic valve regurgitation, cerebral haemorrhage, nonwitnessed cardiac arrest, age over 80 years, and short life expectancy due to underlying neoplastic or other medical condition. Because strict clinical evaluation for inclusion may be difficult in this urgent setting, cases were discussed in detail between the remote team and the coordinating staff.
Decision-making process and procedures
The MUCA left the Groupe Hospitalier Pitié-Salpêtrière within 30 min of phone acceptance for remote ECMO support and attempted retrieval. The MUCA brought the ECMO via ground transportation. Once arrived in the remote hospital, the MUCA surgeon and the physician in charge of the patient updated the clinical assessment, while the perfusionist set up the extracorporeal system and the nurse prepared the surgical field and the instrumentation. The patient was finally included in the cardiac-RESCUE program after the whole team (coordinating staff, MUCA, local physician) re-confirmed the indication to initiate veno-arterial circulatory support. In cases of acute respiratory distress syndrome complicated by temporary hypoxic shock, if the decision was to implant a veno-venous ECMO, the patient was then included in the ongoing pulmonary-RESCUE program (i.e. not included in the current report).
The ECMO device and its implantation technique have been described elsewhere. 1 Briefly, veno-arterial peripheral ECMO was initiated through cannulation of the femoral vessels in intubated and ventilated patients. Circulatory support was initiated within 30 min after the team has confirmed the indication. Thereafter, unstable patients were not considered suitable for transportation, whereas stable patients were transported as soon as possible to the Intensive Care Unit of the Groupe Hospitalier Pitié-Salpêtrière or to one of the two collaborative centres, by a physician-staffed public ambulance (Service d'Aide Médicale Urgente, SAMU) with the assistance of police officers if required. After transportation, management of RESCUE patients was strictly similar to in-house patients. 1 The primary endpoint was survival to hospital discharge following successful ECMO weaning, left ventricular assist-device implantation, or heart transplantation. Additional analyses included (i) identification of independent predictors for in-hospital mortality, (ii) 1-year and long-term survival, and (iii) comparison with in-house patients.
Collected data
Collected data during phone call and on the field in remote hospitals are summarized in Supplementary Files S1 and S2. In an effort to provide a standardized index of the patient's condition, the dosages of inotropic infusions were used to derive an inotropic score, already used in previous reports. 3, 6, 9 Simplified Acute Physiology Score (SAPS) II and Sepsis-related Organ Failure Assessment (SOFA) score have also been calculated. 10, 11 Every patient discharged from hospital has been followed regularly in the local centre or in our institution in cases of cardiac transplantation or long-term assistance, allowing the investigators to document survival, as well as functional status in all surviving patients.
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Statistical methodology
This report was prepared in compliance with the STROBE checklist for observational studies. 12 Parametric tests were used for comparisons when validity conditions were satisfied (t-test for continuous variables and x 2 test for categorical variables). Non-parametric exact tests (Wilcoxon, Mann-Whitney, and exact Fisher test) were used otherwise. The overall survival was estimated using the KaplanMeier approach. Time to death was calculated from the date of RCS to the date of death whatever the cause is or to the date of the last follow-up assessment. A forward selection procedure was used to identify the main risk factors of in-hospital mortality (see Supplementary File S3). Relevant variables significant at the 20% level on univariate analysis were included in a multivariate Cox model. Diagnostic was included as two binary variables. Hazard ratios were then provided with 95% confidence intervals (CIs).
To assess the relative rate of survival to hospital discharge of the cardiac-RESCUE program when compared with ECMO performed in a specialized hospital, we carried out an exposed/unexposed-type analysis using a multivariate logistic model with a variable indicating whether or not a patient was treated in the RESCUE program. Unexposed or controls were consecutive patients hospitalized at the Pitié-Salpêtrière University Hospital for whom veno-arterial ECMO had been performed in the ICU between 1 January 2006 and 31 December 2009 (In-House ECMO group), excluding post-transplantation and post-cardiotomy ECMO. Odds ratio (OR) that compares the odds of dying in the cardiac-RESCUE program with the odds in the specialized hospital was used as a measure of association. To limit the bias from potential confounding factors, conditional logistic regression analysis was stratified on the diagnostic (in three classes) and on the CPR after having checked the homogeneity of the risk assessments in the different strata. ORs were further adjusted on prognostic factors identified at the previous step of the analysis. Model selection was performed to retain the adjustment factors significantly associated to the survival at hospital discharge. As a sensitivity analysis, we estimated the effect of the RESCUE with different adjustment. We systematically included all the variables that were found associated with the life prognostic of patients treated in the RESCUE program but that were not selected in the multivariate model.
All tests were two-tailed and P-values ,0.05 considered statistically significant. All data were analysed using SAS software version 9.1.
Role of the funding source
The funding source had no role in study design, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study, take full responsibility for the integrity of the data and, in consultation with the other lead authors, had final responsibility for the decision to submit for publication.
Results

Study population and feasibility
Between January 2005 and December 2009, 104 RCS cases from 37 remote hospitals ( Figure 1) were identified remotely and discussed for possible on-site (remote) ECMO with the coordinating team centrally. Of these, 11 patients did not fulfil inclusion criteria, mostly because the medical management was not considered optimized. In the 93 other eligible cases, MUCA was initiated. Six patients died before MUCA arrival. Thus, 87 consecutively eligible patients were included in the cardiac-RESCUE program ( Figure 2) .
Patient demographics are summarized in Table 1 . Briefly, the mean age was 46 + 15 years, 68% were males, and the indication for ECMO initiation was acute myocardial infarction in almost half of the cases. Organ failure before ECMO implantation is described in Table 2 . Elevated blood lactate, serum bicarbonate, creatinine, bilirubin and troponin, and reduced prothrombin ratio, together with high SOFA score and SAPS, reflected severe multiorgan failure at ECMO onset. The median time from admission in the remote ICU to MUCA phone call and circulatory support was 1 day (mean 2 + 3.96 days, range 0-25 days). Time from phone call to circulatory support ranged from 64 to 254 min ( Figure 1 and Table 3 ), depending on the distance to the remote centre.
Once stabilized in the remote ICU, 75 patients (86%) were transported to the Groupe Hospitalier Pitié-Salpêtrière (n ¼ 61) or collaborative tertiary centres (n ¼ 14). This transfer was performed within the first 24 h in most cases (87%). We noted no technical incident or adverse event during transport, except one ECMO dysfunction requiring temporary manual assistance. The remaining 12 patients (14%) were not transported because of haemodynamic instability and ultimately died after a median of 2 days.
In-hospital outcomes and mid-term survival
Among the 75 patients who were successfully transported to the expert tertiary centres, 32 patients survived to hospital discharge, giving an in-hospital survival rate of 36.8% (95% CI 27.4-46.2) (Figure 2 ): 28 patients bridged to recovery (including one bilateral lung transplantation) and 4 patients underwent cardiac transplantation including one after a 2-month period of total artificial heart. The median time on ECMO for this group was 7.5 days (mean 9.0, range 1-25 days).
Among those who died, 48 patients (87.3%) died while still receiving ECMO, 4 patients (7.3%) died after implantation of another assist device, and 3 patients (5.4%) died after ECMO weaning. Death was mainly due to refractory multiorgan failure (89.1%) or brain death (10.9%). The median time on ECMO for these patients was 3.5 days (mean 5.8 days, range 0-39 days).
Results of univariate analysis for in-hospital mortality are summarized in Figure 2 Flow chart of the cardiac-RESCUE program. RCS, refractory cardiogenic shock; MUCA, Mobile Unit For Circulatory Assist; V-A ECMO, veno-arterial extracorporeal membrane oxygenation; MOF, multiorgan failure; BTR, bridge to recovery; BTT, bridge to transplantation; BTB, bridge to bridge; TAH, total artificial heart; L-VAD, left ventricular assist device; Bi-VAD, bi-ventricular assist device; Lung Tx, lung transplantation; Heart Tx, heart transplantation.
Cardiac-RESCUE program for remote refractory cardiogenic shock none survived. Of the 13 patients in whom ECMO was started under CPR, only one was alive at discharge.
Fifty-two patients (60%) suffered one to five complications of ECMO during circulatory support. Local complications included femoral bleeding (n ¼ 12, 14%), lower limb ischaemia (n ¼ 11, 13%), surgical wound infection (n ¼ 9, 10%), and femoral vein thrombosis (n ¼ 1, 1%).
Systemic complications included renal failure requiring continuous veno-venous haemodiafiltration (n ¼ 23, 26%), pulmonary oedema (n ¼ 21, 24%), distant bleeding (n ¼ 16, 18%), and major stroke (n ¼ 11, 13%).
All together, 20 patients (23%) required extra surgical interventions. Sixteen conversions to intra-thoracic ECMO (18%) were required for the treatment of pulmonary oedema (n ¼ 11), lower limb ischaemia (n ¼ 1), both (n ¼ 1), or low ECMO output (n ¼ 3). Surgical re-exploration of the groin was necessary four times (5%) as treatment of femoral bleeding (n ¼ 2), surgical wound infection (n ¼ 1), or lower limb ischaemia (n ¼ 1).
Among the 32 patients who were discharged from hospital, the 1-year survival rate was 93.8% (95% CI 79.8 -100). After a median follow-up of 2.2 years (range 1.0 -5.8 years), no patient was lost of follow-up, and four patients died 4, 12, 28, and 45 months after discharge. The remaining 28 patients had a mean New York Heart Association functional class status of 1.5 + 0.6. The longterm survival curve (Figure 3 ) reflected the high in-hospital mortality but favourable late prognosis of discharged patients.
RESCUE vs. in-house analysis
Data from 123 consecutive contemporaneous patients treated at the Pitié-Salpêtrière Hospital were compared with the patients from the Cardiac-RESCUE Program. In-house patients were more often older than 60 (P ¼ 0.03) and had lower SAPS (P ¼ 0.01); the distribution of diagnosis was also different (P , 0.001) with more dilated cardiomyopathy ( Table 5 ). The crude observed in-hospital death rates were 63% both in in-house and in the RESCUE programs. However, due to the differences in several prognostic factors, a multivariate analysis adjusting for potential confounding factors was carried out. In the multivariate analysis adjusted for inotropic score and stratified for diagnosis and CPR, mortality at hospital discharge in the cardiac-RESCUE program group was not found statistically different (OR 1.48, 95% CI 0.72-3.00, P ¼ 0. Cardiac-RESCUE program for remote refractory cardiogenic shock model the SAPS or the age did not modify the main conclusion) and were reassuring regarding the robustness of the results.
Regarding prognostic factors in the in-house group, only inotropic score .20 was found to be statistically associated with a higher risk of death (OR 1.51, 95% CI 1.03-2.11, P ¼ 0.32), but ECMO under CPR, age, history of CPR, oligo-anuria, pH, and diagnosis was not.
Discussion
To the best of our knowledge, this report is the first to prospectively evaluate a dedicated mobile medical care unit for the provision of remote ECMO support to and subsequent transfer of RCS patients. We found that 86% of these critically ill patients could be stabilized and transported to a tertiary-care centre and almost half of these were finally discharged alive from hospital. Circulatory support using ECMO is now recognized as the optimal treatment of RCS patients, with or without cardiac arrest.
2 -4,6,13 However, ECMO is only available in a limited number of tertiary-care centres and this was the rationale for our project. Paris and its region include more than a thousand intensive care beds, but only one-sixth of which are in institutions with local access to advanced circulatory support with ECMO, representing a major limitation for equitable access, even in high population density regions. In this context, the cardiac-RESCUE program was designed to overcome the frequent lack of availability of ECMO and staff trained in its use.
Covering an additional 33 institutions and 607 beds (48%) in Paris and its surrounding area, the RESCUE program has quadrupled the number of ICU beds with ECMO access in this area and constitutes evidence for including extra-institutional salvage circulatory support team in pre-existing regional referral networks. The importance of providing ECMO to remote institutions has been recently emphasized. Preliminary reports from several groups have been encouraging but also urged the need for further evaluation using prospective evaluation, strict patient . selection, and specific dedicated staff to assess whether this strategy is feasible, efficient, and effective. 14 -19 In this context, the cardiac-RESCUE program provides timely information. In stabilizing and facilitating the transfer of over 80% of referred RCS patients, such a service appears feasible and potentially effective. Better identification of prognostic factors in RCS could provide additional data to help refine indications. Compared with in-house ECMO use, our results appear quite similar; recent literature suggests similar median survival rates of expert centre ECMO programs for RCS of 40%. 20, 21 These pilot data suggest that remote institutional salvage with mobile teams to provide circulatory support using ECMO can probably achieve similar results as in-house programs, with appropriate patient selection. Furthermore, the early independent predictors of in-hospital mortality identified in our current study are similar to those previously reported in in-house patients, including RCS aetiology, ECMO implantation during CPR, and severe liver or renal failure. 1 -4 Our data clearly indicate that not all remote patients with RCS would necessarily benefit from a mobile ECMO program. Prognostic factor analysis enabled us to identify that ECMO institution during CPR is a strong predictor of failure of ECMO. In our experience, no such patient became a long-term survivor. This is likely due to the additional at least 30 min delay to reach and implement patients remotely in this specific circumstance, compared with the in-house patients reported in the literature. These results led us not to send the MUCA in such situation. In addition, no patient aged over 62 years survived to hospital discharge in this experience. Nevertheless, older age should be analysed according to the severity of the situation before considering MUCA displacement.
In contrast, it is possible that some patients included in the cardiac-RESCUE program may have benefited from earlier circulatory support and consequent better outcomes if they had been managed earlier in a tertiary-care centre. This underscores the desirability of early and open communications to optimize the potential benefits of an extra-institutional ECMO program. Educational programs may be beneficial, in this regard.
It should be noted that such a program requires the constant availability of specialized medical staff, strong logistic support, and a number of dedicated ICU beds, limiting this activity to large tertiary-care centres. Health economic evaluation would also be important, because the extended use of this highly specialized intervention may sharply raise hospital costs and resource utilization. Our study has limitations. Distances in the Paris area may be shorter than in other more geographically dispersed regions and so our results may not be reproducible where travel times are longer. For ethical considerations, subjects were not randomized to participation in the cardiac-RESCUE program vs. transfer of the patient prior to ECMO initiation. Even though this cohort of patients is the largest described so far, study numbers are relatively small and this experience should be replicated in a variety of other settings, to expand experience with subject selection and technical aspects of support. In particular, any statistical conclusions are limited by the lack of power and the absence of randomization. Only strong differences can be detected, and it is possible that the lack of significant difference between the outcomes in the 'in-house' and in the cardiac-RESCUE program does not imply equivalence. This lack of power is even stronger when investigating effect variations according to subgroups.
Conclusions
Mobile units for the provision of ECMO support to critically ill patients with RCS in remote locations, followed by stabilization and transport to a tertiary-care centre, appear feasible. When ECMO implantation may be placed in time, this strategy potentially allows long-term survival in approximately one-third of these patients, who would likely die otherwise. Patients requiring CPR for cardiac output and the elderly most probably cannot benefit from circulatory support, in this context. These results support the consideration of such specific mobile units to offer advanced circulatory support to selected RCS patients, in remote institution.
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